P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Pandemic Influenza Translational Research and novel universal countermeasure development
|
Research Initiative
|
FDA
|
NIAID
|
|
|
Pathophysiological Actions of Anthrax Virulence Determinants
|
Research Initiative
|
FDA
|
NIAID
|
|
|
PCORTF Frailty Functional Disabilities Project Working Group
|
Research Initiative
|
ASPE, AHRQ, CDC, CMS
|
|
2019
|
|
Physiological Effects of Natural or Contaminating Compounds in a Rodent's Microenvironment
|
Research Initiative
|
FDA
|
NIEHS
|
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Response Team
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Covid Task Force
|
Research Initiative
|
CDC
|
CC
|
2020
|
|
Preclinical and Clinical Investigations of Severe Infection and Critical Illness - CDC Foundation
|
Research Initiative
|
CDC
|
CC
|
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention
|
Research Initiative
|
CDC
|
FIC, NCI, NIAAA, NIAID, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
Production and purification of biological compounds
|
Research Initiative
|
FDA
|
NIDDK
|
|
|